Disease Tolerance as an Inherent Component of Immunity
- PMID: 30673535
- DOI: 10.1146/annurev-immunol-042718-041739
Disease Tolerance as an Inherent Component of Immunity
Abstract
Pathogenic organisms exert a negative impact on host health, revealed by the clinical signs of infectious diseases. Immunity limits the severity of infectious diseases through resistance mechanisms that sense and target pathogens for containment, killing, or expulsion. These resistance mechanisms are viewed as the prevailing function of immunity. Under pathophysiologic conditions, however, immunity arises in response to infections that carry health and fitness costs to the host. Therefore, additional defense mechanisms are required to limit these costs, before immunity becomes operational as well as thereafter to avoid immunopathology. These are tissue damage control mechanisms that adjust the metabolic output of host tissues to different forms of stress and damage associated with infection. Disease tolerance is the term used to define this defense strategy, which does not exert a direct impact on pathogens but is essential to limit the health and fitness costs of infection. Under this argument, we propose that disease tolerance is an inherent component of immunity.
Keywords: damage; disease tolerance; immunoregulation; infection; metabolism; microbiota; nutritional immunity; stress; tissue damage control.
Similar articles
-
Resistance and tolerance defenses in cancer: Lessons from infectious diseases.Semin Immunol. 2017 Aug;32:54-61. doi: 10.1016/j.smim.2017.08.004. Epub 2017 Aug 31. Semin Immunol. 2017. PMID: 28865876 Review.
-
Disease tolerance and immunity in host protection against infection.Nat Rev Immunol. 2017 Feb;17(2):83-96. doi: 10.1038/nri.2016.136. Epub 2017 Jan 3. Nat Rev Immunol. 2017. PMID: 28044057 Review.
-
Disease tolerance as a defense strategy.Science. 2012 Feb 24;335(6071):936-41. doi: 10.1126/science.1214935. Science. 2012. PMID: 22363001 Free PMC article. Review.
-
Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease.Front Immunol. 2018 May 29;9:1077. doi: 10.3389/fimmu.2018.01077. eCollection 2018. Front Immunol. 2018. PMID: 29896192 Free PMC article. Review.
-
Unravelling the networks dictating host resistance versus tolerance during pulmonary infections.Cell Tissue Res. 2017 Mar;367(3):525-536. doi: 10.1007/s00441-017-2572-5. Epub 2017 Feb 6. Cell Tissue Res. 2017. PMID: 28168323 Free PMC article. Review.
Cited by
-
Histopathologic and Immunohistochemical Evaluation of Induced Lesions, Tissue Tropism and Host Responses following Experimental Infection of Egyptian Rousette Bats (Rousettus aegyptiacus) with the Zoonotic Paramyxovirus, Sosuga Virus.Viruses. 2022 Jun 12;14(6):1278. doi: 10.3390/v14061278. Viruses. 2022. PMID: 35746749 Free PMC article.
-
High Lethality of Mycobacterium tuberculosis Infection in Mice Lacking the Phagocyte Oxidase and Caspase1/11.Infect Immun. 2023 Jul 18;91(7):e0006023. doi: 10.1128/iai.00060-23. Epub 2023 Jun 14. Infect Immun. 2023. PMID: 37314361 Free PMC article.
-
New insights into the pathogenesis of leprosy: contribution of subversion of host cell metabolism to bacterial persistence, disease progression, and transmission.F1000Res. 2020 Jan 31;9:F1000 Faculty Rev-70. doi: 10.12688/f1000research.21383.1. eCollection 2020. F1000Res. 2020. PMID: 32051758 Free PMC article. Review.
-
Immunological exhaustion: How to make a disparate concept operational?PLoS Pathog. 2021 Sep 23;17(9):e1009892. doi: 10.1371/journal.ppat.1009892. eCollection 2021 Sep. PLoS Pathog. 2021. PMID: 34555119 Free PMC article. Review.
-
What's new in intensive care: disease tolerance.Intensive Care Med. 2023 Oct;49(10):1235-1237. doi: 10.1007/s00134-023-07130-8. Epub 2023 Jun 23. Intensive Care Med. 2023. PMID: 37353606 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources